SCHEMBL30108065

SCHEMBL30108065

Cc1ncc(-c2cc(-n3nnc4ccccc43)nc(N)n2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 1/20 0.38
PIK3CD O00329 6/20 0.37
PIK3R1 P27986 6/20 0.37
PIK3CA P42336 5/20 0.37
PIK3CB P42338 5/20 0.37
PIK3CG P48736 4/20 0.37
MAPK14 Q16539 2/20 0.35
CCNE1 P24864 3/20 0.35
CDK2 P24941 3/20 0.35
MAPK8 P45983 3/20 0.35
MAPK9 P45984 3/20 0.35
MAPK10 P53779 2/20 0.35
ADORA2A P29274 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108027 0.92 TSHR (0.39) TSHRSMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL30107988 0.86 TSHR (0.33) TSHRSMN1; SMN2KDM4EMAPK14CDK2
SCHEMBL30108003 0.84 MET (0.40) ALDH1A1MAPTHRH4
SCHEMBL30108012 0.72 TSHR (0.58) TSHRSMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL30107965 0.72 MET (0.40) TSHRSMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL29544252 0.65 RAB9A (0.58) TSHRSMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL28563917 0.65 RAB9A (0.58) TSHRSMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL15780431 0.64 RAB9A (0.57) TSHRSMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL20156597 0.64 RAB9A (0.61) TSHRSMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL10103846 0.63 RAB9A (0.59) TSHRSMN1; SMN2RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed